公开(公告)号：US11911744B2

公开(公告)日：2024-02-27

申请号：US17339416

申请日：2021-06-04

申请人： SIMEON INVESTMENT, INC.

发明人： Lijun Sun

IPC分类号： B01J20/24 ,  A61K31/736 ,  B01J20/30

CPC分类号： B01J20/24 ,  A61K31/736 ,  B01J20/3021 ,  B01J20/3078

摘要： Provided are superabsorbent materials composed of agar, and one or more water-soluble natural polysaccharides, and dietary compositions containing such superabsorbent materials. The disclosed superabsorbent materials have various food and therapeutic applications and can be used as loading vehicles for nutrients and therapeutic agents. Also provided are methods for preparing such superabsorbent materials.

公开(公告)号：US11690801B2

公开(公告)日：2023-07-04

申请号：US17344062

申请日：2021-06-10

申请人： Steven J. Edwards

发明人： Steven J. Edwards

IPC分类号： A61F13/00 ,  A61K9/00 ,  A61K35/742 ,  A61K31/047 ,  A61K35/747 ,  A61K31/736 ,  A61K35/745

CPC分类号： A61K9/006 ,  A61K31/047 ,  A61K31/736 ,  A61K35/742 ,  A61K35/745 ,  A61K35/747

摘要： An oral pharmabiotic system is disclosed for improving oral, dental, and systemic health by repopulating and reshaping the flora within a patient's oral environment in a manner that overcomes the deficiencies of prior oral probiotic products. By formulating the pharmabiotic system as a strip for adhesive placement within a patients' oral cavity, preferably against the buccal mucosa, alveolar mucosa, oral labial mucosa, or a dental appliance, and configuring the parameters of the strip such that neither disadhesion nor complete dissolution occurs for at least a period of at least three hours during daytime use and at least six hours during nighttime use, the probiotic payload contained within may remain in the oral cavity for a sufficient length of time required for the probiotics to activate, replicate, and displace existing harmful oral pathobiotics.

公开(公告)号：US20230000901A1

公开(公告)日：2023-01-05

申请号：US17943674

申请日：2022-09-13

申请人： KAECO Group, Inc.

发明人： Kelly Terry ,  Leon Kratochvil ,  James Harless ,  Tom Kratochvil

IPC分类号： A61K31/736 ,  A61K31/198 ,  A61K31/047 ,  A23K50/20 ,  A61K31/355 ,  A61K31/714 ,  A61K31/4415 ,  A61K31/352 ,  A61K9/00 ,  A23K10/20 ,  A61K31/455 ,  A61K35/744 ,  A61K31/51 ,  A61K47/44 ,  A61K9/14 ,  A23K20/174 ,  A61K31/702 ,  A61K33/30 ,  A61K31/525 ,  A23K20/20 ,  A61K33/04 ,  A61K9/10 ,  A23K20/158 ,  A61K35/747 ,  A61K36/22 ,  A23K20/10 ,  A61K36/48 ,  A23K10/18 ,  A23K20/105 ,  A61K31/4188 ,  A61K31/685 ,  A23K10/30

摘要： Embodiments of a method and supplement for preventing and/or treating gastrointestinal distress, including ulcer conditions, in animals such as humans are disclosed. The supplement is in a tablet or capsule form and comprises mastic gum and an emulsifying agent such as lecithin. The supplement may also comprise B vitamins, one or more prebiotics or probiotics, and one or more minerals as well as, pH buffers and flavoring. A disclosed method of preventing and/or treating gastrointestinal distress comprises orally dosing an animal such as a human with the supplement at least once daily.

公开(公告)号：US11439676B2

公开(公告)日：2022-09-13

申请号：US17009416

申请日：2020-09-01

申请人： KAECO Group, Inc.

发明人： Kelly Terry ,  Leon Kratochvil ,  James Harless ,  Tom Kratochvil

IPC分类号： A61K31/736 ,  A61K35/747 ,  A61K36/22 ,  A61K47/24 ,  A61P1/00 ,  A61K9/107 ,  A61K31/714 ,  A61K35/744

摘要： Embodiments of a method and supplement for preventing and/or treating gastrointestinal distress, including ulcer conditions, in animals such as humans are disclosed. The supplement is in a gel or other form and comprises mastic gum and an emulsifying agent such as lecithin. The supplement may also comprise B vitamins, one or more prebiotics or probiotics, and one or more minerals as well as, pH buffers and flavoring. A disclosed method of preventing and/or treating gastrointestinal distress comprises orally dosing an animal such as a human with the supplement at least once daily.

公开(公告)号：US20220211732A1

公开(公告)日：2022-07-07

申请号：US17613220

申请日：2020-05-18

申请人： Evonik Operations GmbH

发明人： Bodo SPECKMANN ,  Christopher STUDTE

IPC分类号： A61K31/7004 ,  A61K31/202 ,  A61K31/732 ,  A61K31/716 ,  A61K31/719 ,  A61K31/702 ,  A61K31/736 ,  A61K9/48 ,  A61P1/14

摘要： The invention discloses preparations comprising L-rhamnose, and the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the form of either free fatty acids, fatty acid salts having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, or mixtures of free fatty acids and omega-3 fatty acid salts having an organic counter ion selected from lysine, arginine, ornithine, choline and use of a preparation as a feed or food supplement or in pharmaceutical compositions.

公开(公告)号：US11376275B2

公开(公告)日：2022-07-05

申请号：US17060343

申请日：2020-10-01

申请人： Alcon Inc.

发明人： James W. Davis ,  Howard Allen Ketelson ,  Elaine E. Campbell ,  David L. Meadows ,  Rekha Rangarajan

IPC分类号： A61K31/736 ,  A61K9/00 ,  A61K47/02 ,  A61K47/10 ,  A61K47/26 ,  A61K47/36 ,  A61K47/32 ,  A61K31/728

摘要： The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the to compositions also comprise a borate compound.

公开(公告)号：US10973245B2

公开(公告)日：2021-04-13

申请号：US16311503

申请日：2017-06-09

申请人： YESSINERGY HOLDING S/A

发明人： Victor Abou Nehmi Filho

IPC分类号： A23K20/163 ,  A61K47/54 ,  A61K31/7016 ,  A61K31/702 ,  A61K31/716 ,  A61K31/736 ,  A61K36/06 ,  A61K36/064 ,  A61K31/733

摘要： This invention relates to a composition for additives which can be employed in animal feeds, or as growth promoters, or as nutraceuticals, or as prebiotics, or as additives for the control and prophylaxis of pathogenic bacteria in the intestinal tract of animals or farmed animals. An immunomodulatory and promoter composition for controlling the population of undesirable bacteria of the intestinal microbiota, comprising the components indicated below: (a) Fructooligosaccharides (FOS); (b) Galacto-oligosaccharides (GOS); (c) Mannan-oligosaccharides (MOS); (d) 1,3 and 1,6 Beta-glucans.

公开(公告)号：US20210100832A1

公开(公告)日：2021-04-08

申请号：US17060101

申请日：2020-10-01

申请人： Patchor Ltd.

发明人： Inessa Solomonik ,  Shachar Patchornik ,  Dror Robinson

IPC分类号： A61K31/736 ,  A61K31/728 ,  A61K31/722 ,  A61L27/20 ,  A61K9/00 ,  A61K9/70 ,  A61P19/02

摘要： Described herein are compositions and methods of use thereof for treatment of musculoskeletal disorders by way of administering at least one galectin inhibitor to a subject, such as galactoarabino-rhamnogalacturonan (GR) and derivatives thereof, and galactomannan (GM) and derivatives thereof. In particular embodiments the described compounds are administered in combination with hyaluronic acid or Chitosan.

公开(公告)号：US20210069236A1

公开(公告)日：2021-03-11

申请号：US16981355

申请日：2019-03-25

申请人： INSTITUT POLYTECHNIQUE DE GRENOBLE ,  CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS- ,  UNIVERSITE GRENOBLE ALPES ,  CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE ALPES

发明人： Christine CHIRAT ,  Bertrand TOUSSAINT ,  Vivien DELOULE ,  Jadwiga CHROBOCZEK ,  Claire BOISSET-HELBERT

IPC分类号： A61K31/736 ,  A61P1/14

摘要： The field of the invention is that of prebiotic compositions.
In particular, the invention relates to a prebiotic composition comprising galactoglucomannans, and also the production method thereof.
The invention also targets the use of this prebiotic composition for increasing production of short-chain fatty acids by bacteria of the intestinal microbiota.

公开(公告)号：US20190255096A1

公开(公告)日：2019-08-22

申请号：US16281316

申请日：2019-02-21

申请人： Novartis AG

发明人： Howard Allen Ketelson ,  James W. Davis ,  Rekha Rangarajan

IPC分类号： A61K31/736 ,  A61K9/00 ,  A61K9/107 ,  A61K47/14 ,  A61K47/24 ,  A61P27/02

摘要： The present invention is directed to a lipid-based ophthalmic emulsion. The emulsion has an increased amount of a mucoadhesive galactomannan polymer that promotes a long-lasting protection against desiccation and moisture retention.